Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2025

Aug 21, 2025

34129_dirs_2025-08-21_457fe0ff-4777-4b06-91a6-025c310aca7a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2025-08-19

Reporting Person: HEIDEN WILLIAM K (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-08-19 Common Stock P 50500 $1.52 Acquired 61500 Direct
2025-08-20 Common Stock P 49500 $1.49 Acquired 111000 Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $1.48 to $1.59. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

F2: This transaction was executed in multiple trades at prices ranging from $1.46 to $1.50. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.